These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 19235537)
1. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro. Rumberger B; Kreutz C; Nickel C; Klein M; Lagoutte S; Teschner S; Timmer J; Gerke P; Walz G; Donauer J Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):283-92. PubMed ID: 19235537 [TBL] [Abstract][Full Text] [Related]
2. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens. Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299 [TBL] [Abstract][Full Text] [Related]
3. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation. Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355 [TBL] [Abstract][Full Text] [Related]
4. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells. Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807 [TBL] [Abstract][Full Text] [Related]
5. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells. Puzik A; Schultz C; Iblher P; Müller-Steinhardt M; Härtel C Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416 [TBL] [Abstract][Full Text] [Related]
6. The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes. Weaver JL; Pine PS; Aszalos A Immunopharmacol Immunotoxicol; 1994 May; 16(2):179-90. PubMed ID: 7521360 [TBL] [Abstract][Full Text] [Related]
8. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans. Böhler T; Nolting J; Kamar N; Gurragchaa P; Reisener K; Glander P; Neumayer HH; Budde K; Klupp J Ther Drug Monit; 2007 Feb; 29(1):77-86. PubMed ID: 17304154 [TBL] [Abstract][Full Text] [Related]
9. Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures. Oliveira VD; Zankl H; Rath T Exp Clin Transplant; 2004 Dec; 2(2):273-9. PubMed ID: 15859941 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin. Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411 [TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells. Buron F; Perrin H; Malcus C; Héquet O; Thaunat O; Kholopp-Sarda MN; Moulin FT; Morelon E Transplant Proc; 2009 Oct; 41(8):3347-52. PubMed ID: 19857747 [TBL] [Abstract][Full Text] [Related]
12. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor. Niemczyk M; Zegarska J; Pawłowska M; Wyzgał J; Ciszek M; Paczek L Transpl Immunol; 2009 Jan; 20(3):139-42. PubMed ID: 18834941 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice. Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187 [TBL] [Abstract][Full Text] [Related]
14. The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo. Boldt A; Barten MJ; Sagner A; Mohr FW; Adams V; Dhein S; Gummert JF Transplantation; 2006 Aug; 82(3):422-7. PubMed ID: 16906043 [TBL] [Abstract][Full Text] [Related]
15. [Immunology in clinical practice. VI. Current immunosuppressive drugs]. ten Berge RJ; Schellekens PT Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813 [TBL] [Abstract][Full Text] [Related]
16. Everolimus and sirolimus antagonize tacrolimus based calcineurin inhibition via competition for FK-binding protein 12. van Rossum HH; Romijn FP; Smit NP; de Fijter JW; van Pelt J Biochem Pharmacol; 2009 Apr; 77(7):1206-12. PubMed ID: 19154728 [TBL] [Abstract][Full Text] [Related]
17. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. Patsenker E; Schneider V; Ledermann M; Saegesser H; Dorn C; Hellerbrand C; Stickel F J Hepatol; 2011 Aug; 55(2):388-98. PubMed ID: 21168455 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats. Kyles AE; Gregory CR; Craigmill AL Am J Vet Res; 2000 Aug; 61(8):906-9. PubMed ID: 10951980 [TBL] [Abstract][Full Text] [Related]
19. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients. Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405 [TBL] [Abstract][Full Text] [Related]
20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]